Contact Supplier

Contact Supplier

To get in touch with Bachem AG, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    Bachem Granted Manufacturing License by Japanese Ministry of Health Labour and Welfare

    news-releasesBachem AG
    November 15th 2012

    Bachem AG, the internationally recognized manufacturer of the highest quality biochemical and pharmaceutical drug products for the pharma and biotech industry has been granted a renewed manufacturing license in conformity by the Japanese Ministry of Health, Labour and Welfare (MHLW). The license allows Bachem to continue to manufacture active pharmaceutical ingredients intended for the Japanese market.

    All three of Bachem’s GMP production facilities – Switzerland based, Bachem AG in Bubendorf and Bachem SA, Succursale de Vionnaz and US based Bachem Americas, Inc. in Torrance, California have met the strong requirements to achieve the license and supply the Japanese market for many years.

    The license and Bachem’s extensive experience in the registration of master files in Japan allows the company to supply Japan based pharmaceutical and biotech companies with the required quantities of APIs ranging from small quantities for development projects to bulk deliveries for successfully marketed products.

    About Bachem
    Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries.

    It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio.

    Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership.

    Bachem. Pioneering Partner for Peptides

    Press Contact:
    Bachem Holding AG
    Stephan Schindler
    Chief Financial Officer
    Tel: +41 61 935 23 33
    Email: [email protected]

    For more information or to discuss Bachem granted manufacturing license by Japanese MHLW please contact us directly.

    Resources

    Click on Bachems News to see latest News & Events.

    TRENDING ARTICLE

    Bachem – Partner from Research to Marketed API

    FREE DOWNLOAD

    Contact Bachem AG

    Simply fill out the form below to contact Bachem AG now.

    Send Bachem AG a Message